# Vascular Surgical Antibiotic Prophylaxis Study (VSAPS 2)

> **NCT01612052** · PHASE4 · UNKNOWN · sponsor: **CAMC Health System** · enrollment: 200 (estimated)

## Conditions studied

- MRSA - Methicillin Resistant Staphylococcus Aureus Infection

## Interventions

- **DRUG:** Antibiotic Prophylaxis

## Key facts

- **NCT ID:** NCT01612052
- **Lead sponsor:** CAMC Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2013-03
- **Final completion:** 2013-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2013-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01612052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01612052, "Vascular Surgical Antibiotic Prophylaxis Study (VSAPS 2)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01612052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*